XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 27, 2021
Mar. 28, 2020
Net sales $ 225,488 $ 138,921
Cost and expenses:    
Cost of sales (1) [1] 123,283 82,837
Research and development 23,152 22,468
Selling, general and administrative 32,739 33,352
Amortization of purchased intangible assets 9,244 9,538
Restructuring charges 1,340 403
Impairment charges 0 3,949
Costs and Expenses, Total 189,758 152,547
Income (loss) from operations 35,730 (13,626)
Other (expense) income:    
Interest expense (2,575) (4,427)
Interest income 50 147
Foreign transaction loss (262) (404)
Loss on extinguishment of debt (1,761) 0
Income (loss) from continuing operations before taxes 31,182 (18,310)
Income tax provision (benefit) 3,575 (992)
Income (loss) from continuing operations 27,607 (17,318)
Income from discontinued operations 0 42
Net income (loss) $ 27,607 $ (17,276)
Basic:    
Income (loss) from continuing operations (in dollars per share) $ 0.63 $ (0.42)
Income from discontinued operations (in dollars per share) 0 0.00
Net income (loss) (in dollars per share) 0.63 (0.42)
Diluted:    
Income (loss) from continuing operations (in dollars per share) 0.61 (0.42)
Income from discontinued operations (in dollars per share) 0 0.00
Net income (loss) (in dollars per share) $ 0.61 $ (0.42)
Weighted average shares used in computing income (loss) per share:    
Basic (in shares) 43,756 41,502
Diluted (in shares) 45,482 41,502
Cash dividend, per share (in dollars per share) $ 0 $ 0.06
[1] Excludes amortization of $7,101 and $7,266 for the three months ended March 27, 2021 and March 28, 2020, respectively.